- PLATFORM LOGINS
- |
- CONTACT
- Request a Demo
-
Major commercial insurer renews contract of NaviNet Open and adds NantHealth’s Document Exchange solution to their rolodex
Along with extending their contract, BCBSNE adds NantHealth’s
“As adoption of value-based care programs continues to grow among payers
and providers, there is a critical need to establish more collaborative
partnerships,” said Dr.
BCBSNE was an original Beta partner for the
NaviNet Open Document Exchange enables a HIPAA-safe exchange of clinical information among multiple medical management, informatics, and care delivery teams with the goal of empowering health plans to better communicate and engage with their provider networks in real-time. The flexible solution allows providers to easily access, review, modify, and return documents in pursuit of population health and fee-for-value program initiatives. By meshing clinical intelligence with administrative workflows, NaviNet Open Document Exchange enables effective payer-provider collaboration to improve patient outcomes and boost efficiency.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, among others, statements regarding the capabilities and
anticipated utility of our GPS Cancer, including predicting patient
response and resistance to therapeutics, enabling diagnoses by
physicians and accelerating efforts to bring novel combinations of
therapeutic agents to cancer patients. Forward-looking statements are
subject to numerous risks and uncertainties that could cause actual
results to differ materially from currently anticipated results. Factors
that may cause future results to differ materially from management’s
current expectations include, among other things, that GPS Cancer may
not perform as anticipated, that sufficient physicians may not adopt GPS
Cancer to assist their diagnoses or that healthcare payers may not
provide reimbursement for GPS Cancer as expected. Our business is
subject to numerous additional risks and uncertainties, including, among
others, risks relating to market acceptance of our products; our ability
to successfully launch new products and applications; competition; our
sales, marketing and distribution capabilities; our planned sales,
marketing, and research and development activities; unanticipated
increases in costs or expenses; and risks associated with international
operations. Information on these and additional risks, uncertainties,
and other information affecting our business and operating results can
be found in our existing and future filings with the
About
About Blue Cross Blue Shield Nebraska
View source version on businesswire.com: http://www.businesswire.com/news/home/20170801005560/en/
jen@nantworks.com
Source: